Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003658 |
---|---|
Receipt number | R000004429 |
Scientific Title | Randomized phase II study of gemcitabine monotherapy versus gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer (YCOG001) |
Date of disclosure of the study information | 2010/05/24 |
Last modified on | 2015/01/18 03:25:55 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/05/24 15:44:59 | ||
2 | Update | 2015/01/18 03:24:28 | TEL Institute Institute Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2015/01/18 03:25:55 | Recruitment status |